Paper · 41543183
<p>Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review)</p>.
Rauschenberg S and 7 others. Int J Oncol, 2026. Cited by 1 paper, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. <p>Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review)</p>. Papers, record 41543183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41543183
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- <p>Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review)</p>.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Pancreatic Ductal | Major topic |
| Pancreatic Neoplasms | Major topic |
| Humans | |
| Female | |
| Prognosis | |
| Male | |
| Tumor Microenvironment | |
| Sex Factors | |
| Risk Factors | |
| Biomarkers, Tumor | |
| Sex Characteristics |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References118
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41,258,799 | Estrogen Production in Pancreatic Cancer Shapes a Tumor-Suppressive Stromal Microenvironment. | Cancer Res | 2026 | https://conductscience.org/library/papers/41258799 | PubMed |
| 2 | 38,307,029 | Multimodal immune phenotyping reveals microbial-T cell interactions that shape pancreatic cancer. | Cell Rep Med | 2024 | https://conductscience.org/library/papers/38307029 | PubMed |
| 3 | 35,272,420 | MTHFR c.665C>T guided fluoropyrimidine therapy in cancer: gender-dependent effect on dose requirements. | Drug Metab Pers Ther | 2022 | https://conductscience.org/library/papers/35272420 | PubMed |
| 4 | 38,906,254 | Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma. | Ann Oncol | 2024 | https://conductscience.org/library/papers/38906254 | PubMed |
| 5 | 33,573,202 | Gender Differences in Patients with Metastatic Pancreatic Cancer Who Received FOLFIRINOX. | J Pers Med | 2021 | https://conductscience.org/library/papers/33573202 | PubMed |
| 6 | 20,826,833 | Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic Syndrome and Cancer Project. | Cancer Epidemiol Biomarkers Prev | 2010 | https://conductscience.org/library/papers/20826833 | PubMed |
| 7 | 32,147,593 | Burden of Pancreatic Cancer: From Epidemiology to Practice. | Clin Gastroenterol Hepatol | 2021 | https://conductscience.org/library/papers/32147593 | PubMed |
| 8 | 34,239,137 | Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. | Nat Med | 2021 | https://conductscience.org/library/papers/34239137 | PubMed |
| 9 | 25,954,090 | Sex- and gender-specific disparities in colorectal cancer risk. | World J Gastroenterol | 2015 | https://conductscience.org/library/papers/25954090 | PubMed |
| 10 | 31,398,337 | Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. | Cell | 2019 | https://conductscience.org/library/papers/31398337 | PubMed |
1 to 10 of 118
See all 118 referencesCited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,963,543 | KRAS in pancreatic cancer: from molecular biology to transformative therapeutics. | J Hematol Oncol | 2026 | https://conductscience.org/library/papers/42963543 | PubMed |
| 42,935,641 | Global and registry-based patterns of pancreatic cancer: GLOBOCAN 2020, CI5plus trends (2000-2017), and demographic projections to 2040. | Front Oncol | 2026 | https://conductscience.org/library/papers/42935641 | PubMed |
| 42,918,883 | CT features of extra-pancreatic nerve plexus invasion predict mortality in early-stage pancreatic cancer. | Eur Radiol | 2026 | https://conductscience.org/library/papers/42918883 | PubMed |
| 42,897,482 | Coordinated upregulation of Hippo, NF-κB and interferon pathway genes in pancreatic ductal adenocarcinoma: a retrospective tissue qRT-PCR profiling study with external tumour-versus-non-tumour validation, molecular subtype and survival analyses. | BMC Gastroenterol | 2026 | https://conductscience.org/library/papers/42897482 | PubMed |
| 42,319,629 | A systematic scoping review of the molecular pathogenesis of digestive system cancers (2013-2025). | Discov Oncol | 2026 | https://conductscience.org/library/papers/42319629 | PubMed |
Genes44
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADIPOQ | 9,370 | PubTator's text mining | https://conductscience.org/library/genes/9370 | NCBI Gene |
| APC | 324 | PubTator's text mining | https://conductscience.org/library/genes/324 | NCBI Gene |
| AR | 367 | PubTator's text mining | https://conductscience.org/library/genes/367 | NCBI Gene |
| BICD1 | 636 | PubTator's text mining | https://conductscience.org/library/genes/636 | NCBI Gene |
| CCL2 | 6,347 | PubTator's text mining | https://conductscience.org/library/genes/6347 | NCBI Gene |
| CD163 | 9,332 | PubTator's text mining | https://conductscience.org/library/genes/9332 | NCBI Gene |
| CDKN2A | 1,029 | PubTator's text mining | https://conductscience.org/library/genes/1029 | NCBI Gene |
| CDKN2B | 1,030 | PubTator's text mining | https://conductscience.org/library/genes/1030 | NCBI Gene |
| CDX2 | 1,045 | PubTator's text mining | https://conductscience.org/library/genes/1045 | NCBI Gene |
| CEACAM3 | 1,084 | PubTator's text mining | https://conductscience.org/library/genes/1084 | NCBI Gene |
1 to 10 of 44
See all 44 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41543183
GET https://conductscience.org/api/papers/v1/41543183/references?page=2